首页 | 本学科首页   官方微博 | 高级检索  
检索        


The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy
Authors:Hong-Yuan Lin
Institution:Forth Medical Center, General Hospital of PLA, Beijing, China
Abstract:COVID-19 is known for its magical infectivity, fast transmission and high death toll based on the large number of infected people. From the perspective of the clinical manifestation, autopsy examination and pathophysiology, the essence of COVID-19 should be viewed as a sepsis induced by viral infection, and has the essential characteristics as sepsis induced by other pathogens. Therefore, in addition to etiological and supportive treatment, immunomodulatory therapy is also appropriate to severe COVID-19. Although there is still a lack of consensus on immunotherapy for sepsis so far, relatively rich experiences have been accumulated in the past decades, which will help us in the treatment of severe COVID-19. This article will elaborate immunotherapy of sepsis, though it may not be consistent.
Keywords:COVID-19SepsisImmunomodulatory therapyImmunotherapyUlinastatinThymosin a1
点击此处可从《中华创伤杂志(英文版)》浏览原始摘要信息
点击此处可从《中华创伤杂志(英文版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号